NewEdge Advisors’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-300
Closed -$543 3919
2024
Q3
$543 Hold
300
﹤0.01% 3595
2024
Q2
$504 Hold
300
﹤0.01% 3567
2024
Q1
$774 Sell
300
-200
-40% -$466 ﹤0.01% 3536
2023
Q4
$990 Hold
500
﹤0.01% 3468
2023
Q3
$465 Hold
500
﹤0.01% 3262
2023
Q2
$570 Sell
500
-238
-32% -$207 ﹤0.01% 3303
2023
Q1
$519 Hold
738
﹤0.01% 3235
2022
Q4
$1 Buy
+738
New +$644 ﹤0.01% 3989

Other funds holding CGEN

NewEdge Advisors's CGEN Position: Q4 2024 in Review

NewEdge Advisors sold out of Compugen (CGEN) in Q4 2024, closing a stake of 300 shares — an estimated $543 sold.

NewEdge Advisors first reported a position in CGEN in Q4 2022 and held it in 8 quarters. The position peaked at $990 in Q4 2023. 70 funds tracked by Wall St. Rank hold CGEN as of Q4 2024.

  • NewEdge Advisors reported no remaining Compugen position as of Q4 2024 after selling out during the quarter.
  • NewEdge Advisors sold 300 Compugen shares in Q4 2024, an estimated $543.
  • NewEdge Advisors first reported a position in Compugen in Q4 2022 and held it in 8 quarters.
  • NewEdge Advisors's Compugen position peaked at $990 in Q4 2023.
  • 70 funds tracked by Wall St. Rank held Compugen as of Q4 2024.

Based on NewEdge Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.